Wilcoxon statistic (Area Under the Curve) [ Time Frame: T0+2h (end of each technique) ] [ Designated as safety issue: No ]

An Linear Discriminant Analysis (LDA) will be used to discriminate target and Algorithm performance (Wilcoxon statistic) for discrimination between occurrent and non-occurrent stimuli.

Signals will adequately be pre-processed: denoised and spatialy filtered (xDAWN). The Area Under the Receiver Operator Characteristic Curve (AUC) also called wilcoxon statistic will be used to identify the signals of best quality.

with 3 electrodes : 3 different types of electrodes at the time (needle, cupule 5mm, cupule 10mm)

Other Name: EEG recording

Detailed Description:

Brain Computer Interface (BCI) are used to restore control and communication in patient with severe disabilities such as Locked In Syndrome (LIS) patients.

The aim of this study is to identify the most relevant recording technique for extraction of P300 ERPs in EEG signals. Three different electrodes (needle, standard ,silver) will be simultaneously compared in a prospective design in 10 healthy volunteers, as suggested by principal investigator.

Eligibility

Ages Eligible for Study:

18 Years to 80 Years

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

Yes

Criteria

Inclusion Criteria:

Healthy volunteers male or female aging over 18

Signed informed consent

Passed the preliminary exam

Registered in the national database for persons willing to participate in Biomedical research

Exclusion Criteria:

Visual or hearing problems

Cognitive problems

Illiterate persons

Persons under Guardianship or Trusteeship

Having Epilepsy

Pregnant women Not covered by the social security system

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01518426